Bispecific antibody 2 articles

Within its parent topic, bispecific antibody is the dual-target engineered antibody modality associated most directly with dual-antigen binding. Biologically, two-target antibody architecture and T-cell engager antibodies provide the central mechanism, with tumor cell immune synapse formation and CD3 bispecific antibodies marking the measurement, therapeutic or research context. Bispecific antibodies are distinguished from conventional monoclonal antibodies by their two-target architecture, which can bridge cells or block two pathways at once.